Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea · Delayed Price · Currency is KRW 4,755.00
-10.00 (-0.21%)
At close: May 29, 2026
Optipharm.CO.,LTD Market Cap
Optipharm.CO.,LTD has a market cap or net worth of 69.76 billion as of June 1, 2026. Its market cap has decreased by -9.60% in one year.
Market Cap
69.76B
Enterprise Value
71.37B
Revenue
22.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,755.00
Market Cap Chart
Since October 26, 2018, Optipharm.CO.,LTD's market cap has decreased from 166.34B to 69.76B, a decrease of -58.06%. That is a compound annual growth rate of -10.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 69.76B | -6.76% |
| Dec 30, 2025 | 74.82B | 9.80% |
| Dec 30, 2024 | 68.14B | -33.93% |
| Dec 28, 2023 | 103.13B | 0.29% |
| Dec 29, 2022 | 102.84B | -25.09% |
| Dec 30, 2021 | 137.29B | -37.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Sam-A Pharm. | 88.56B |
| Polaris AI Pharma | 84.88B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 76.46B |
| GL Pharm Tech | 74.06B |
| Hwail Pharmaceutical | 68.27B |